The client of Chinanews.com, June 7 (China) today released the white paper "China Action Against New Coronary Pneumonia". The white paper pointed out that at present, four inactivated vaccines and one adenovirus vector vaccine have been approved for clinical trials, and the overall R&D progress is the same as abroad.
White paper: The overall R&D progress of China's new coronary pneumonia vaccine is on par with foreign countries
2020-06-07T03:03:12.083Z
The client of Chinanews.com, June 7 (China) today released the white paper "China Action Against New Coronary Pneumonia". The white paper pointed out that at present, four inactivated vaccines and one adenovirus vector vaccine have been approved for clinical trials, and the overall R&D progress is the same as abroad. ...
Source: chinanews